… bacteriophages for treating urinary tract infections (UTIs). Bacteriophages were actively instilled
into the bladder and … Pyophage was regularly adapted according to an Appelmans' base …

… phage adaptation cycles, respectively. The second phase included the treatment of patient
with adapted Pyo bacteriophage … and safety of adapted phage therapy in the treatment of UTIs…

… natural phages, genetically engineered phages, and phage lytic enzymes (PLEs) as an
alternative antimicrobial treatment for urinary tract infections… with phages or PLEs for treatment of …

… urinary infections is a phase II/III study in Georgia that targets “urinary tract infections in …
The design of this study using the phage cocktail named “Pyo” has been published, but not …

|Isolation and characterization of novel bacteriophages as a potential therapeutic option for
Escherichia coli urinary tract infections | Applied Microbiology and Biotechnology Skip to …

… coli in TSB and urine, we tested phage against biofilms formed in urine. To identify phage
with broad anti-biofilm activity in urine, phage were tested against two E. coli strains, DS515 …

… aureus), 41% of the strains were sensitive to the action of the Pyo bacteriophage, and after
its four-fold adaptation, the sensitivity of the bacteria increased to 75%. In the second part of …

… a bacteriophage cocktail to treat a 56-year-old male liver transplant patient with complex,
recurrent prostate and urinary tract infections … adaptive immune response to the UCS1 phage …

… trial investigating bacteriophages for treating urinary tract infections in … infection site. When
time and resources permit, these bacteriophages are adapted or trained—ie, bacteriophage …

The Lancet Infectious Diseases Page 1 The Lancet Infectious Diseases Intravesical
bacteriophages for treating urinary tract infections A randomised, placebocontrolled, double-blind …